Oncogene:对环氧酶2调控的蛋白裂解酶激活的抑制能抑制前列腺癌细胞死亡和转移

2017-04-30 AlexYang MedSci原创

慢性炎症在癌症的发生和发展中具有重要作用。环氧合酶-2(COX-2)在产生前列腺素并引起炎症中是一个关键的酶,COX-2在前列腺癌(PCa)中经常超表达并且和PCa细胞的侵入和转移相关。最近,有研究人员就COX-2促进PCa细胞侵入和转移的分子机制和COX-2抑制剂在选择的PCa发展模型中的效应进行了研究。研究结果表明,在高度侵入性PCa细胞中,COX-2和白介素1β(IL-1β)的表达上调,并且

慢性炎症在癌症的发生和发展中具有重要作用。环氧合酶-2(COX-2)在产生前列腺素并引起炎症中是一个关键的酶,COX-2在前列腺癌(PCa)中经常超表达并且和PCa细胞的侵入和转移相关。

最近,有研究人员就COX-2促进PCa细胞侵入和转移的分子机制和COX-2抑制剂在选择的PCa发展模型中的效应进行了研究。研究结果表明,在高度侵入性PCa细胞中,COX-2和白介素1β(IL-1β)的表达上调,并且与膜锚定的丝氨酸蛋白裂解酶的激活水平相关。在PCa样品中,COX-2的表达水平增加并且与蛋白裂解酶的水平相关。更多的是,COX-2的超表达或者COX-2的产物前列腺素E2(PGE2)可以引起蛋白裂解酶活性的增加和PCa细胞的侵入,而COX-2的沉默可起到相反的作用。另外,在原位异种种植模型中,西乐葆和硫化舒林酸产生的环氧酶2调控的蛋白裂解酶激活的抑制可以抑制不依赖雄激素和COX-2超表达的PCa PC-2细胞侵入、肿瘤生长和肺转移。最后,研究人员指出,COX-2/蛋白裂解酶信号可以导致侵入、肿瘤生长和COX-2超表达和不依赖雄激素PCa细胞转移。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2048821, encodeId=155c20488211c, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Sep 14 03:39:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709788, encodeId=35a01e0978822, content=<a href='/topic/show?id=128e904112c' target=_blank style='color:#2F92EE;'>#裂解酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90411, encryptionId=128e904112c, topicName=裂解酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96b31789917, createdName=12498cbcm10(暂无昵称), createdTime=Mon Jun 12 00:39:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252235, encodeId=d34f1252235fc, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558068, encodeId=5f181558068a3, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620207, encodeId=0d23162020ea8, content=<a href='/topic/show?id=c62132549a5' target=_blank style='color:#2F92EE;'>#前列腺癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32549, encryptionId=c62132549a5, topicName=前列腺癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09820091072, createdName=lifestar, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-09-14 cy0324
  2. [GetPortalCommentsPageByObjectIdResponse(id=2048821, encodeId=155c20488211c, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Sep 14 03:39:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709788, encodeId=35a01e0978822, content=<a href='/topic/show?id=128e904112c' target=_blank style='color:#2F92EE;'>#裂解酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90411, encryptionId=128e904112c, topicName=裂解酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96b31789917, createdName=12498cbcm10(暂无昵称), createdTime=Mon Jun 12 00:39:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252235, encodeId=d34f1252235fc, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558068, encodeId=5f181558068a3, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620207, encodeId=0d23162020ea8, content=<a href='/topic/show?id=c62132549a5' target=_blank style='color:#2F92EE;'>#前列腺癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32549, encryptionId=c62132549a5, topicName=前列腺癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09820091072, createdName=lifestar, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2048821, encodeId=155c20488211c, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Sep 14 03:39:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709788, encodeId=35a01e0978822, content=<a href='/topic/show?id=128e904112c' target=_blank style='color:#2F92EE;'>#裂解酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90411, encryptionId=128e904112c, topicName=裂解酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96b31789917, createdName=12498cbcm10(暂无昵称), createdTime=Mon Jun 12 00:39:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252235, encodeId=d34f1252235fc, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558068, encodeId=5f181558068a3, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620207, encodeId=0d23162020ea8, content=<a href='/topic/show?id=c62132549a5' target=_blank style='color:#2F92EE;'>#前列腺癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32549, encryptionId=c62132549a5, topicName=前列腺癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09820091072, createdName=lifestar, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-05-02 yxch36
  4. [GetPortalCommentsPageByObjectIdResponse(id=2048821, encodeId=155c20488211c, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Sep 14 03:39:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709788, encodeId=35a01e0978822, content=<a href='/topic/show?id=128e904112c' target=_blank style='color:#2F92EE;'>#裂解酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90411, encryptionId=128e904112c, topicName=裂解酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96b31789917, createdName=12498cbcm10(暂无昵称), createdTime=Mon Jun 12 00:39:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252235, encodeId=d34f1252235fc, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558068, encodeId=5f181558068a3, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620207, encodeId=0d23162020ea8, content=<a href='/topic/show?id=c62132549a5' target=_blank style='color:#2F92EE;'>#前列腺癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32549, encryptionId=c62132549a5, topicName=前列腺癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09820091072, createdName=lifestar, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=)]
    2017-05-02 zsyan
  5. [GetPortalCommentsPageByObjectIdResponse(id=2048821, encodeId=155c20488211c, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Thu Sep 14 03:39:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709788, encodeId=35a01e0978822, content=<a href='/topic/show?id=128e904112c' target=_blank style='color:#2F92EE;'>#裂解酶#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90411, encryptionId=128e904112c, topicName=裂解酶)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c96b31789917, createdName=12498cbcm10(暂无昵称), createdTime=Mon Jun 12 00:39:00 CST 2017, time=2017-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252235, encodeId=d34f1252235fc, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558068, encodeId=5f181558068a3, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620207, encodeId=0d23162020ea8, content=<a href='/topic/show?id=c62132549a5' target=_blank style='color:#2F92EE;'>#前列腺癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32549, encryptionId=c62132549a5, topicName=前列腺癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e09820091072, createdName=lifestar, createdTime=Tue May 02 00:39:00 CST 2017, time=2017-05-02, status=1, ipAttribution=)]

相关资讯

Int J Cancer:咖啡可降低患前列腺癌的风险!

一项最新研究表明,每天三杯或更多杯可降低前列腺癌的风险。通过实验室实验也证实了抗肿瘤作用。

Nature:现有免疫治疗搞不定的前列腺癌,被华人科学家用新方法搞定了

在美国,前列腺癌作为一种发病率排名第一,死亡率排名第四的癌症,让美国男性饱受折磨。尤其是其中一种叫做耐雄激素限制疗法的转移性前列腺癌(metastatic castration-resistant prostate cancer, mCRPC),更是要命,五年存活率只有28%。被誉为癌症治疗新希望的免疫疗法目前对mCRPC一点办法也没有,二期临床实验(NCT02601014)表示CTLA-4/PD

Prostate Cancer P D: 在不患有转移性前列腺癌男性群体中,共存疾病负担与更高等级肿瘤的联系

尽管较大的年龄与更高级别的肿瘤相关,但是,共存性疾病负担是否有着相似的、独立的联系还不被人们所知。最近,有研究人员就共存性疾病负担对肿瘤等级的影响进行了评估,该评估利用了活检格林森评分。在两个医疗中心中,研究人员将1260名且在1998年到2004年新诊断为非转移性前列腺癌的男性作为群体进行了观察性群体研究。另外,研究人员利用多变量顺序和多项式逻辑回归来评估查尔森合并症指数得分和活检格林森得分。研

Oncogene: CRIPTO和它的信号伴侣GRP78能促使人类前列腺癌骨转移表型

CRIPTO (CR-1,TDGF1)是一个细胞表面/分泌的肿瘤蛋白并积极的参与发育和癌症。最近,研究人员报道了CRIPTO的高表达与前列腺癌(PCa)患者分层风险组的低生存率有关。研究结果发现,CRIPTO和它的信号伴侣-葡萄糖调节的蛋白78(GRP78)在PCa转移肿瘤中高度表达,并且与非转移性ALDHlow比较,在PC-3M-Pro4Luc2 PCa 细胞的转移性ALDHhigh亚群中有着更

Prostate Cancer P D:总量和酒精饮料摄入与侵入性前列腺癌风险

酒精饮料中的乙醇是知名的致癌物质,但是它与侵入性前列腺癌(APC)的关系却并不知晓。近期的一些研究指出,APC患病率的一定程度增加与大量酒精摄入有关系,但是对酒精饮料的类型仍旧不清楚。最近,研究人员利用案例-对照设计和自我陈述调查就APC与酒精摄入频率和量的关系进行了研究,酒精摄入超过两年的优先考虑,并且APC包括高级和晚期两种阶段。更多的是,研究人员描述了酒精饮料啤酒、红酒、白酒和烈酒与APC的

Sci Rep:丙酮酸激酶M2的抑制明显的减弱了晚期膀胱癌对铂化合物的化学抵抗性

铂化合物的化学抵抗性是导致晚期膀胱癌(BC)治疗失败的致死的主要原因。但是,潜在的机制仍旧不清楚,这也阻碍了治疗策略的发展。最近的研究数据表明丙酮酸激酶M2(PKM2),一个瓦博格效应糖解酶,在BC中的表达水平强烈地提高了。最近,有研究人员就PKM2在化学抵抗性中的角色和是否抑制PKM2就可以增加对铂化合物的抵抗性和减少BC生长和发展进行了研究。研究发现,紫草素结合PKM2并能抑制BC细胞存活,且